Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails
Investor's Business DailySage Therapeutics said Wednesday its Biogen-partnered treatment for essential tremor failed in a study, leading Sage stock to collapse.
The post Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails appeared first on Investor�…